Search research articles
Contact Us
Filters
Showing results (441-450 of 473) with videos related to
Page
of 48
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 30, 2015
Changes in the influence of lymphoma- and HIV-specific factors on outcomes in AIDS-related non-Hodgkin lymphoma
S K Barta, M S Samuel, X Xue, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1996
Feasibility and results of bone marrow transplantation after remission induction and intensification chemotherapy in de novo acute myeloid leukemia. Catalan Group for Bone Marrow Transplantation
J Sierra, S Brunet, A Grañena, et al.
Haematologica
|
April 22, 2006
Effect of chemotherapy with alkylating agents on the yield of CD34+ cells in patients with multiple myeloma. Results of the Spanish Myeloma Group (GEM) Study
Javier de la Rubia, Joan Bladé, Juan-José Lahuerta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 30, 2008
Prognostic value of immunophenotyping in multiple myeloma: a study by the PETHEMA/GEM cooperative study groups on patients uniformly treated with high-dose therapy
Gema Mateo, M Angeles Montalbán, Maria-Belén Vidriales, et al.
Leukemia Research
|
August 13, 2005
Adverse prognostic impact of CD36 and CD2 expression in adult de novo acute myeloid leukemia patients
G Perea, A Domingo, N Villamor, et al.
Leukemia
|
June 7, 2017
Long-term outcome of older patients with newly diagnosed de novo acute promyelocytic leukemia treated with ATRA plus anthracycline-based therapy
D Martínez-Cuadrón, P Montesinos, E Vellenga, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 5, 2024
Human immunodeficiency virus-associated lymphomas: EHA-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
K Hübel, M Bower, I Aurer, et al.
Bone Marrow Transplantation
|
January 9, 2021
Allogeneic hematopoietic stem cell transplantation for advanced mycosis fungoides and Sézary syndrome. An updated experience of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation
E Domingo-Domenech, R F Duarte, A Boumedil, et al.
Actas Dermo-Sifiliograficas
|
May 24, 2014
Evidence-based guidelines of the spanish psoriasis group on the use of biologic therapy in patients with psoriasis in difficult-to-treat sites (nails, scalp, palms, and soles)
M Sánchez-Regaña, M J Aldunce Soto, I Belinchón Romero, et al.
Haematologica
|
August 28, 2001
Additional cytogenetic changes do not influence the outcome of patients with newly diagnosed acute promyelocytic leukemia treated with an ATRA plus anthracyclin based protocol. A report of the Spanish group PETHEMA
J M Hernández, G Martín, N C Gutiérrez, et al.
Page
of 48
Search research articles
Search
Showing results (441-450 of 473) with videos related to
Sort By:
Page
of 48
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 30, 2015
Changes in the influence of lymphoma- and HIV-specific factors on outcomes in AIDS-related non-Hodgkin lymphoma
S K Barta, M S Samuel, X Xue, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1996
Feasibility and results of bone marrow transplantation after remission induction and intensification chemotherapy in de novo acute myeloid leukemia. Catalan Group for Bone Marrow Transplantation
J Sierra, S Brunet, A Grañena, et al.
Haematologica
|
April 22, 2006
Effect of chemotherapy with alkylating agents on the yield of CD34+ cells in patients with multiple myeloma. Results of the Spanish Myeloma Group (GEM) Study
Javier de la Rubia, Joan Bladé, Juan-José Lahuerta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 30, 2008
Prognostic value of immunophenotyping in multiple myeloma: a study by the PETHEMA/GEM cooperative study groups on patients uniformly treated with high-dose therapy
Gema Mateo, M Angeles Montalbán, Maria-Belén Vidriales, et al.
Leukemia Research
|
August 13, 2005
Adverse prognostic impact of CD36 and CD2 expression in adult de novo acute myeloid leukemia patients
G Perea, A Domingo, N Villamor, et al.
Leukemia
|
June 7, 2017
Long-term outcome of older patients with newly diagnosed de novo acute promyelocytic leukemia treated with ATRA plus anthracycline-based therapy
D Martínez-Cuadrón, P Montesinos, E Vellenga, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 5, 2024
Human immunodeficiency virus-associated lymphomas: EHA-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
K Hübel, M Bower, I Aurer, et al.
Bone Marrow Transplantation
|
January 9, 2021
Allogeneic hematopoietic stem cell transplantation for advanced mycosis fungoides and Sézary syndrome. An updated experience of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation
E Domingo-Domenech, R F Duarte, A Boumedil, et al.
Actas Dermo-Sifiliograficas
|
May 24, 2014
Evidence-based guidelines of the spanish psoriasis group on the use of biologic therapy in patients with psoriasis in difficult-to-treat sites (nails, scalp, palms, and soles)
M Sánchez-Regaña, M J Aldunce Soto, I Belinchón Romero, et al.
Haematologica
|
August 28, 2001
Additional cytogenetic changes do not influence the outcome of patients with newly diagnosed acute promyelocytic leukemia treated with an ATRA plus anthracyclin based protocol. A report of the Spanish group PETHEMA
J M Hernández, G Martín, N C Gutiérrez, et al.
Page
of 48